Perrigo Company (PRGO) Shares Sold by Mitsubishi UFJ Kokusai Asset Management Co. Ltd.
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. cut its position in shares of Perrigo Company (NYSE:PRGO) by 32.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,442 shares of the company’s stock after selling 12,969 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Perrigo were worth $2,072,000 as of its most recent filing with the SEC.
Other institutional investors also recently made changes to their positions in the company. Schwab Charles Investment Management Inc. increased its position in shares of Perrigo by 4.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 429,676 shares of the company’s stock worth $32,450,000 after buying an additional 18,095 shares in the last quarter. Global X Management Co. LLC increased its position in shares of Perrigo by 37.9% in the second quarter. Global X Management Co. LLC now owns 3,269 shares of the company’s stock worth $247,000 after buying an additional 899 shares in the last quarter. TD Asset Management Inc. increased its position in shares of Perrigo by 24.1% in the second quarter. TD Asset Management Inc. now owns 67,838 shares of the company’s stock worth $5,123,000 after buying an additional 13,169 shares in the last quarter. Retirement Systems of Alabama increased its position in shares of Perrigo by 0.3% in the second quarter. Retirement Systems of Alabama now owns 69,515 shares of the company’s stock worth $5,250,000 after buying an additional 210 shares in the last quarter. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management bought a new position in shares of Perrigo during the second quarter worth about $14,700,000. Institutional investors and hedge funds own 76.30% of the company’s stock.
Shares of Perrigo Company (NYSE:PRGO) opened at 77.77 on Wednesday. The company has a 50-day moving average of $73.71 and a 200-day moving average of $73.13. The firm’s market capitalization is $11.14 billion. Perrigo Company has a 52 week low of $63.68 and a 52 week high of $99.14.
Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $0.94 by $0.28. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. The firm had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same period in the previous year, the business earned $1.93 earnings per share. Perrigo’s revenue for the quarter was down 7.7% compared to the same quarter last year. On average, equities analysts forecast that Perrigo Company will post $4.50 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 25th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.82%. The ex-dividend date of this dividend is Wednesday, August 23rd. Perrigo’s dividend payout ratio (DPR) is presently -3.51%.
A number of brokerages have recently issued reports on PRGO. Wells Fargo & Company reiterated a “market perform” rating and issued a $77.00 price target on shares of Perrigo in a report on Tuesday. Stifel Nicolaus reiterated a “hold” rating on shares of Perrigo in a report on Friday, August 11th. Jefferies Group LLC reiterated a “hold” rating and issued a $71.00 price target (up previously from $69.00) on shares of Perrigo in a report on Friday, August 11th. Royal Bank Of Canada increased their price target on shares of Perrigo from $60.00 to $64.00 and gave the company an “underperform” rating in a report on Friday, August 11th. Finally, Goldman Sachs Group, Inc. (The) upgraded shares of Perrigo from a “sell” rating to a “neutral” rating and increased their price target for the company from $66.00 to $79.00 in a report on Friday, August 11th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company. Perrigo presently has a consensus rating of “Hold” and a consensus target price of $86.83.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company (NYSE:PRGO).
Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with Analyst Ratings Network's FREE daily email newsletter.